Clal Biotechnology reported ILS21.05M in Trade Creditors for its fiscal quarter ending in December of 2021.





Trade Creditors Change Date
Arca Biopharma USD 6.67M 2.5M Mar/2026
aTyr Pharma USD 2.76M 52.32M Mar/2026
Bio Path USD 5.16M 260K Mar/2026
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Cara Therapeutics USD 4.62M 1.4M Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.53M 173K Mar/2026
Immunic USD 11.01M 873K Mar/2026
Minerva Neurosciences USD 640K 305K Dec/2025
RedHill Biopharma USD 731K 104K Dec/2025
TherapeuticsMD USD 143K 4K Jun/2024